African Health Sciences
Makerere University Medical School
Vol. 18, No. 4, 2018, pp. 1003-1009
Bioline Code: hs18124
Full paper language: English
Document type: Study
Document available free of charge
African Health Sciences, Vol. 18, No. 4, 2018, pp. 1003-1009
© Copyright 2018 - Manafa et al.
A comparative study of carbohydrate antigen 19-9 in sickle cell disease subjects and controls in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria|
Manafa, Patrick; Okocha, Chide; Nwogho, Benedict; Aneke, John; Okpara, Paul Smith Davis; lbeh, Nancy; Chukwuma, George; Manafa, Vera & Nwane, Ejike
Background: Sickle cell disease is characterized by chronic complications that affect almost all body organs. Pancreatic disease
is rare in SCD. CA 19-9 is a non-specific surrogate marker for pancreatic disease especially carcinoma. CA 19-9 levels have not
been evaluated in SCD patients in our environment.
Objectives: The study aimed to compare the levels of CA 19-9 in homozygous sickle cell disease subjects in steady state with
those of (Hb AS) and normal healthy subjects (Hb AA)
Method: Seventy nine subjects including 39 Hb SS, 19 Hb AS and 21 Hb AA subjects were recruited in a cross-sectional study in
Nnamdi Azikiwe University and Teaching Hospital. Haemoglobin genotype and CA 19-9 estimation were done using Hb electrophoresis and enzyme linked immunosorbent assay respectively. Data was analyzed with IBM SPSS 21. P value was set at 0.05.
Result: The mean CA 19-9 (U/ml) level in Hb SS, Hb AS and Hb AA were 13.6 ± 7.6, 15.3 ± 9.9, and 20.0 ± 15.9 respectively.
[Reference value <37U/ml] CA 19-9 was significantly lower in Hb SS compared to Hb AA subjects (p = 0.035).
Conclusion: Low levels of CA 19-9 in Hb SS may suggest reduced pancreatic disorders in SCA.
Hemoglobin phenotype; disease severity; carbohydrate antigen 9-19; pancreatic disease; sickle cell disease.